NCT01395823View on ClinicalTrials.gov

Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

470

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

June 30, 2015

Conditions
End Stage Renal Disease
Interventions
DIETARY_SUPPLEMENT

ergocalciferol supplementation

50,000 IU given either weekly; weekly for 3 months then monthly for 3 months; monthly

OTHER

placebo

placebo pill given weekly, weekly for 3 months then monthly for 3 months; monthly

Trial Locations (12)

19129

DCI - Philadelphia, Philadelphia

31701

DCI - Albany, Albany

37804

DCI - Maryville, Maryville

37924

DCI - Knoxville, Knoxville

64131

DCI - Kansas City, Kansas City

65201

DCI- Columbia, Columbia

68131

DCI- Omaha, Omaha

71103

DCI - Shreveport, Shreveport

96003

DCI - Redding, Redding

02111

DCI - Boston, Boston

08903

DCI - New Brunswick, New Brunswick

08902

DCI - North Brunswick, North Brunswick

All Listed Sponsors
lead

Dialysis Clinic, Inc.

INDUSTRY